Literature DB >> 15654195

The remarkable right ventricle of patients with Eisenmenger syndrome.

William E Hopkins1.   

Abstract

Patients with Eisenmenger syndrome do much better than patients with all other etiologies of severe pulmonary hypertension. The primary reason, and a major focus of this review, is the right ventricle, a remarkable chamber with preserved systolic function despite a lifetime of systemic level pulmonary hypertension.

Entities:  

Mesh:

Year:  2005        PMID: 15654195     DOI: 10.1097/00019501-200502000-00004

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  22 in total

1.  Right ventricular nitric oxide signaling in an ovine model of congenital heart disease: a preserved fetal phenotype.

Authors:  Rebecca Johnson Kameny; Youping He; Catherine Morris; Christine Sun; Michael Johengen; Wenhui Gong; Gary W Raff; Sanjeev A Datar; Peter E Oishi; Jeffrey R Fineman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-05-01       Impact factor: 4.733

2.  Adaptive right ventricular performance in response to acutely increased afterload in a lamb model of congenital heart disease: evidence for enhanced Anrep effect.

Authors:  Rebecca C Johnson; Sanjeev A Datar; Peter E Oishi; Stephen Bennett; Jun Maki; Christine Sun; Michael Johengen; Youping He; Gary W Raff; Andrew N Redington; Jeffrey R Fineman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-21       Impact factor: 4.733

3.  From short-term benefits to long-term outcomes: the evolution of clinical trials in pulmonary arterial hypertension.

Authors:  Murali M Chakinala; Robyn Barst
Journal:  Pulm Circ       Date:  2013-12-04       Impact factor: 3.017

4.  Effect of bosentan therapy on ventricular and atrial function in adults with Eisenmenger syndrome. A prospective, multicenter study using conventional and Speckle tracking echocardiography.

Authors:  Mohamed Y Abd El Rahman; Axel Rentzsch; Philipp Scherber; Siegrun Mebus; Oliver Miera; Günther Balling; Petra Böttler; Karl-Otto Dubowy; Birgit Farahwaschy; Alfred Hager; Joachim Kreuder; Brigitte Peters; Felix Berger; Ingram Schulze-Neick; Hashim Abdul-Khaliq
Journal:  Clin Res Cardiol       Date:  2014-03-30       Impact factor: 5.460

5.  Right ventricular remodeling in idiopathic and scleroderma-associated pulmonary arterial hypertension: two distinct phenotypes.

Authors:  Benjamin W Kelemen; Stephen C Mathai; Ryan J Tedford; Rachel L Damico; Cecilia Corona-Villalobos; Todd M Kolb; Neal F Chaisson; Traci Housten Harris; Stefan L Zimmerman; Ihab R Kamel; David A Kass; Paul M Hassoun
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

6.  Statin therapy improves survival in patients with severe pulmonary hypertension: a propensity score matching study.

Authors:  Luise Holzhauser; Ninel Hovnanians; Parham Eshtehardi; M Khalid Mojadidi; Yi Deng; David Goodman-Meza; Pavlos Msaouel; Yi-An Ko; Ronald Zolty
Journal:  Heart Vessels       Date:  2017-03-16       Impact factor: 2.037

7.  Right ventricular involution: What can we learn from nature's model of compensated hypertrophy?

Authors:  Megan E Bowen; Xiaoqing Liu; Peter M Sundwall; Stavros G Drakos; Dean Y Li; Craig H Selzman; Stephen H McKellar
Journal:  J Thorac Cardiovasc Surg       Date:  2017-12-19       Impact factor: 5.209

8.  2014 Guidelines of Taiwan Society of Cardiology (TSOC) for the Management of Pulmonary Arterial Hypertension.

Authors:  Chih-Hsin Hsu; Wan-Jing Ho; Wei-Chun Huang; Yu-Wei Chiu; Tsu-Shiu Hsu; Ping-Hung Kuo; Hsao-Hsun Hsu; Jia-Kan Chang; Chin-Chang Cheng; Chao-Lun Lai; Kae-Woei Liang; Shoa-Lin Lin; Hsao-Hsun Sung; Wei-Chuan Tsai; Ken-Pen Weng; Kai-Sheng Hsieh; Wei-Hsian Yin; Shing-Jong Lin; Kuo-Yang Wang
Journal:  Acta Cardiol Sin       Date:  2014-09       Impact factor: 2.672

Review 9.  Molecular Mechanisms of Right Ventricular Failure.

Authors:  Sushma Reddy; Daniel Bernstein
Journal:  Circulation       Date:  2015-11-03       Impact factor: 29.690

Review 10.  Adult congenital heart disease with pulmonary arterial hypertension: mechanisms and management.

Authors:  Michail Papamichalis; Andrew Xanthopoulos; Panagiotis Papamichalis; John Skoularigis; Filippos Triposkiadis
Journal:  Heart Fail Rev       Date:  2020-09       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.